NYSE$CHE

Chemed Corp · Q1 2022 earnings

Q1 2022 earnings · · Investor relations

Briefing

Chemed's financial performance for Q1 2022 was reported, with revenue up slightly but mixed results across its segments.

Chemed Corporation reported a slight increase in revenue for Q1 2022, with overall revenue rising by 0.6% to $531 million. While Roto-Rooter saw a revenue increase, VITAS experienced a decline. GAAP EPS increased by 5.2% to $4.22, and adjusted EPS increased by 7.9% to $4.79.

  • Chemed's revenue increased by 0.6% to $531 million.
  • GAAP Diluted Earnings-per-Share (EPS) increased 5.2% to $4.22.
  • Adjusted Diluted EPS increased 7.9% to $4.79.
  • Roto-Rooter's revenue increased 9.4%, while VITAS' net patient revenue decreased by 5.3%.

Headline financials

Total Revenue

$531M

Previous: $527M+0.6%
EPS (adj)

$4.79

Previous: $4.44+7.9%
Average Daily Census

17.3K

Previous: 18.1K-4.1%
VITAS Admissions

16.5K

Previous: 18.1K-8.9%
Capital Expenditures

-$12.6M

Previous: -$17.7M+28.5%
Free Cash Flow

$51.5M

Previous: $47.7M+8.0%
Net Income

$64.2M

Previous: $65.4M-1.9%
Operating Income

$89.4M

Previous: $80.4M+11.1%
Gross Profit

$194M

Previous: $187M+3.8%
Cash & Equivalents

$18.2M

Previous: $210M-91.4%
Total Assets

$1.31B

Previous: $1.46B-10.5%

Revenue & EPS history

Chemed · Revenue · Quarterly

$531M

Q1 2022+0.6%vs Q1 2021
Beat estimate in 10 of 16 quarters(63%)
ActualEstimate

Revenue by segment

Chemed · $530M total across 2 segments · Q1 2022

  • VITAS Healthcare
    $299M-5.4%
  • Roto-Rooter
    $231M+9.0%

Forward guidance

Management anticipates providing updated 2022 earnings guidance as part of the June 30, 2022, earnings press release.

Historical earnings impact

How earnings announcements have historically affected this stock's price.

Avg. return before/after earnings

Based on 20 quarterly earnings reports · overlaid with Q1 2022

Historical avgQ1 2022

+0.7%

Avg return

Earnings day

+0.9%

Avg return

5 days after

+2.1%

Avg return

30 days after

53%

36 / 68 earnings

Positive

+13.0%

Q3 2015

Best reaction

-14.8%

Q4 2025

Worst reaction

Earnings price reactions
QuarterReport dateReaction (Day 0)+5 days+30 days
Q1 2026-0.4%-0.1%+4.0%
Q4 2025-14.8%-9.1%-21.0%
Q3 2025+6.0%+0.4%+0.1%
Q1 2025-6.6%-1.8%-2.7%
Q4 2024+7.4%+7.7%+11.0%
Q3 2024-12.0%-12.7%-6.2%
Q2 2024-0.1%+2.4%+5.7%
Q1 2024-7.0%-8.1%-9.9%
Q4 2023+5.1%+2.6%+7.3%
Q3 2023+9.3%+10.9%+14.4%
Q2 2023-8.1%-8.0%-10.8%
Q1 2023-3.7%-2.2%-4.1%
Q4 2022+3.3%+1.7%+1.9%
Q3 2022+3.2%+4.1%+12.6%
Q2 2022-6.8%-9.2%-8.3%
Q1 2022-1.4%-1.0%+0.8%
Q4 2021+5.1%+5.8%+3.8%
Q3 2021+9.2%+9.0%+9.4%
Q2 2021-4.4%-0.4%-2.4%
Q1 2021+1.5%+2.3%+6.1%
Q4 2020-0.8%-6.7%-3.9%
Q3 2020+1.2%+3.5%+0.2%
Q2 2020+9.0%+10.3%+12.2%
Q1 2020-3.9%-6.5%+5.6%
Q4 2019+3.2%-1.2%-23.1%
Q3 2019-1.7%+0.6%+5.9%
Q2 2019+3.7%+8.1%+13.9%
Q1 2019-0.6%+0.7%+0.3%
Q4 2018+1.3%+2.8%+1.9%
Q3 2018+6.2%+6.6%+7.6%
Q2 2018+0.4%-2.5%+0.1%
Q1 2018+3.0%+3.3%+13.4%
Q4 2017+2.4%+2.1%+12.9%
Q3 2017+9.1%+5.0%+12.7%
Q2 2017-1.1%-2.3%-6.3%
Q1 2017+10.0%+9.4%+9.0%
Q4 2016+1.9%+2.0%+9.1%
Q3 2016-0.3%+1.8%+6.3%
Q2 2016+5.0%+3.0%-7.9%
Q1 2016-6.7%
Q4 2015-5.6%
Q3 2015+13.0%
Q2 2015+5.1%
Q1 2015-4.7%
Q4 2014+7.5%
Q3 2014-1.2%
Q2 2014+4.3%
Q1 2014-3.3%
Q4 2013+10.5%
Q3 2013-5.2%
Q2 2013-7.3%
Q1 2013+3.4%
Q4 2012+4.9%
Q3 2012-2.0%
Q2 2012+5.1%
Q1 2012+2.9%
Q4 2011+0.0%
Q3 2011+1.5%
Q2 2011-5.8%
Q1 2010-2.6%
Q1 2011+1.8%
Q4 2008-1.6%
Q4 2010-1.6%
Q3 2009+1.4%
Q3 2010+1.4%
Q2 2010-0.9%
Q2 2009-0.9%
Q4 2009-0.9%

Discussion

Share your read of this quarter. Sign-in carries your eToro identity.

Join the conversation

Sign in with eToro to post your read of this quarter and vote on others'.

Sign in with eToro